Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT06307457
Eligibility Criteria:
Inclusion Criteria:
* Patients with breast cancer (ICD-10: C50)
* A diagnosis of HR+/HER2- locally advanced or metastatic breast cancer
* Endocrine sensitive, endocrine resistant, or de novo mBC patient
* Inclusion date: Date of relapse/stage IV disease/progression leading to initiation of palbociclib+AI
Exclusion Criteria:
* There are no exclusion criteria for this study
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06307457
Study Brief:
Protocol Section:
NCT06307457